medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2024-03-19 ms1000000779917067 来自云南省

有没有转投meidcine成功的

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2024-01-29 苦行僧难上加难来自江西省

under review就是准备送外审了吗？

25 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2024-01-02 ms9000001415022170 来自吉林省

sci怎么不更新medicine了

18 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2024-02-24 ms4000002086897803 来自北京

偏重的研究方向：Meta;Meta分析
经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样

17 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2024-02-24 zll2020 来自四川省

为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗

16 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2024-03-17 山大学医者来自山东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：幽门螺杆菌
经验分享：回顾性对照研究，6个审稿人，无尖锐问题

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2023-02-06 ms8000001700343785 来自辽宁省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肥胖;meta
经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。
我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗

41 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2024-03-12 ms3000000594665618 来自四川省

偏重的研究方向：Meta分析
经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？

15 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2023-10-18 ms8000001025994613

请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗

30 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析 经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：幽门螺杆菌 经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2113230, encodeId=824d2113230c3, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;meta 经验分享：12.7投稿，中间因为格式修了好几次，提交成功后，1.7号回来了一审意见，没有说明是大修还是小修，三个专家给出了20多条意见，修改后，1.24号提交，2.4号accept，现在到了等待proof阶段。 我想问下有大佬知道，proof回来后能修改通讯作者名字吗？以及增加两名作者名字吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ff8300342, createdName=ms8000001700343785, createdTime=Mon Feb 06 13:34:47 CST 2023, time=2023-02-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192722, encodeId=cc712192e22a0, content=偏重的研究方向：Meta分析 经验分享：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.这个状态已经五天了，好着急啊，请问一下机会大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fe9098340, createdName=ms3000000594665618, createdTime=Tue Mar 12 10:49:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2163624, encodeId=7b2f2163624bc, content=请问各位大佬这个杂志大概好久能收到proof啊我10.7号交了版面费到现在也没有收到proof 有相似情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab278177983, createdName=ms8000001025994613, createdTime=Wed Oct 18 22:27:29 CST 2023, time=2023-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149896, encodeId=5f102149896e9, content=今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35208590268, createdName=ms4000001680328946, createdTime=Wed Jul 26 10:00:50 CST 2023, time=2023-07-26, status=1, ipAttribution=四川省)]

2023-07-26 ms4000001680328946 来自四川省

今天收到邮件说：All of the initial requested reviews for your submission have been received; however, further reviews may be necessary. You will be notified of the editorial decision regarding the submission as soon as it is received.现在在Required Reviews Completed状态，这是不是说明专家意见有拒绝的可能啊。还是回复邮件模板就是这个？望大神解答下，谢谢

48 16

展开16条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务